Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Healthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.

Tame CPI Still Spells Trouble for Fed’s Favored Inflation Gauge
34:45

Iran Picks Khamenei’s Son as Next Leader
07:32

Admin's Mixed Messages on Iran Stoke More Volatility
33:15